Global Albendazole Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Albendazole Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Albendazole Market Size Growth Rate by Product
  • 1.4.2 Capsule
  • 1.4.3 Tablet
• 1.5 Market by End User
  • 1.5.1 Global Albendazole Market Size Growth Rate by End User
  • 1.5.2 Pinworm Infection Treatment
  • 1.5.3 Ascaris Infection Treatment
  • 1.5.4 Other Parasitic Infections Treatment
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Albendazole Market Size
  • 2.1.1 Global Albendazole Revenue 2014-2025
  • 2.1.2 Global Albendazole Sales 2014-2025
• 2.2 Albendazole Growth Rate by Regions
  • 2.2.1 Global Albendazole Sales by Regions
  • 2.2.2 Global Albendazole Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Albendazole Sales by Manufacturers
  • 3.1.1 Albendazole Sales by Manufacturers
  • 3.1.2 Albendazole Sales Market Share by Manufacturers
  • 3.1.3 Global Albendazole Market Concentration Ratio (CR5 and HHI)
• 3.2 Albendazole Revenue by Manufacturers
  • 3.2.1 Albendazole Revenue by Manufacturers (2014-2019)
  • 3.2.2 Albendazole Revenue Share by Manufacturers (2014-2019)
• 3.3 Albendazole Price by Manufacturers
• 3.4 Albendazole Manufacturing Base Distribution, Product Types
  • 3.4.1 Albendazole Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Albendazole Product Type
  • 3.4.3 Date of International Manufacturers Enter into Albendazole Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Albendazole Sales by Product
• 4.2 Global Albendazole Revenue by Product
• 4.3 Albendazole Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Albendazole Breakdown Data by End User

6 North America

• 6.1 North America Albendazole by Countries
  • 6.1.1 North America Albendazole Sales by Countries
  • 6.1.2 North America Albendazole Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Albendazole by Product
• 6.3 North America Albendazole by End User

7 Europe

• 7.1 Europe Albendazole by Countries
  • 7.1.1 Europe Albendazole Sales by Countries
  • 7.1.2 Europe Albendazole Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Albendazole by Product
• 7.3 Europe Albendazole by End User

8 Asia Pacific

• 8.1 Asia Pacific Albendazole by Countries
  • 8.1.1 Asia Pacific Albendazole Sales by Countries
  • 8.1.2 Asia Pacific Albendazole Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Albendazole by Product
• 8.3 Asia Pacific Albendazole by End User

9 Central & South America

• 9.1 Central & South America Albendazole by Countries
  • 9.1.1 Central & South America Albendazole Sales by Countries
  • 9.1.2 Central & South America Albendazole Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Albendazole by Product
• 9.3 Central & South America Albendazole by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Albendazole by Countries
  • 10.1.1 Middle East and Africa Albendazole Sales by Countries
  • 10.1.2 Middle East and Africa Albendazole Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Albendazole by Product
• 10.3 Middle East and Africa Albendazole by End User

11 Company Profiles

• 11.1 CHANGZHOU YABANG
  • 11.1.1 CHANGZHOU YABANG Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 CHANGZHOU YABANG Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 CHANGZHOU YABANG Albendazole Products Offered
  • 11.1.5 CHANGZHOU YABANG Recent Development
• 11.2 GlaxoSmithKline
  • 11.2.1 GlaxoSmithKline Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GlaxoSmithKline Albendazole Products Offered
  • 11.2.5 GlaxoSmithKline Recent Development
• 11.3 Huazhong Pharmaceutical
  • 11.3.1 Huazhong Pharmaceutical Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Huazhong Pharmaceutical Albendazole Products Offered
  • 11.3.5 Huazhong Pharmaceutical Recent Development
• 11.4 Hubei Zhongjia-chem Pharmaceutical
  • 11.4.1 Hubei Zhongjia-chem Pharmaceutical Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Hubei Zhongjia-chem Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Hubei Zhongjia-chem Pharmaceutical Albendazole Products Offered
  • 11.4.5 Hubei Zhongjia-chem Pharmaceutical Recent Development
• 11.5 HUBEI KEYI
  • 11.5.1 HUBEI KEYI Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 HUBEI KEYI Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 HUBEI KEYI Albendazole Products Offered
  • 11.5.5 HUBEI KEYI Recent Development
• 11.6 Sequent Scientifi
  • 11.6.1 Sequent Scientifi Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Sequent Scientifi Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Sequent Scientifi Albendazole Products Offered
  • 11.6.5 Sequent Scientifi Recent Development
• 11.7 Lasa Laboratory Pvt Ltd
  • 11.7.1 Lasa Laboratory Pvt Ltd Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Lasa Laboratory Pvt Ltd Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Lasa Laboratory Pvt Ltd Albendazole Products Offered
  • 11.7.5 Lasa Laboratory Pvt Ltd Recent Development
• 11.8 K.A.Malle Pharmaceuticals
  • 11.8.1 K.A.Malle Pharmaceuticals Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 K.A.Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 K.A.Malle Pharmaceuticals Albendazole Products Offered
  • 11.8.5 K.A.Malle Pharmaceuticals Recent Development
• 11.9 Supharma Chem
  • 11.9.1 Supharma Chem Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Supharma Chem Albendazole Products Offered
  • 11.9.5 Supharma Chem Recent Development
• 11.10 Salius Pharma
  • 11.10.1 Salius Pharma Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Salius Pharma Albendazole Products Offered
  • 11.10.5 Salius Pharma Recent Development
• 11.11 Fredun Pharmaceuticals Ltd
• 11.12 Ashish life Science Pvt. Ltd.
• 11.13 AdvacarePharma
• 11.14 MANAV DRUGS
• 11.15 Leo Bio-Care Pvt.

12 Future Forecast

• 12.1 Albendazole Market Forecast by Regions
  • 12.1.1 Global Albendazole Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Albendazole Revenue Forecast by Regions 2019-2025
• 12.2 Albendazole Market Forecast by Product
  • 12.2.1 Global Albendazole Sales Forecast by Product 2019-2025
  • 12.2.2 Global Albendazole Revenue Forecast by Product 2019-2025
• 12.3 Albendazole Market Forecast by End User
• 12.4 North America Albendazole Forecast
• 12.5 Europe Albendazole Forecast
• 12.6 Asia Pacific Albendazole Forecast
• 12.7 Central & South America Albendazole Forecast
• 12.8 Middle East and Africa Albendazole Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Albendazole Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details